VYNE Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Stuart Iain | Chief Scientific Officer | Award / Grant | 27,530 | — | — | 86,982 | Apr 3, 2020 |
| Hirsch Stanley | — | Award / Grant | 71,303 | — | — | 201,410 | Apr 3, 2020 |
| Bruno Anthony D | — | Award / Grant | 75,690 | — | — | 120,123 | Apr 3, 2020 |
| Basta Steven L | — | Award / Grant | 14,499 | — | — | 536,537 | Apr 3, 2020 |
| Harsch Mutya | Chief Legal Officer and GC | Tax Withholding | 1,688 | $2.68 | $4,524 | 56,503 | Mar 31, 2020 |
| Wiley Matthew T. | Chief Commercial Officer | Tax Withholding | 525 | $2.68 | $1,407 | 67,051 | Mar 31, 2020 |
| Stuart Iain | Chief Scientific Officer | Tax Withholding | 1,940 | $2.68 | $5,199 | 59,452 | Mar 31, 2020 |
| Domzalski David | President and CEO | Tax Withholding | 4,456 | $2.68 | $11,942 | 187,496 | Mar 31, 2020 |
| Saik Andrew | Chief Financial Officer | Award / Grant | 50,000 | — | — | 50,000 | Mar 23, 2020 |
| Wiley Matthew T. | Chief Commercial Officer | Award / Grant | 46,680 | — | — | 67,576 | Mar 9, 2020 |
| Stuart Iain | Chief Scientific Officer | Award / Grant | 7,306 | — | — | 7,306 | Mar 9, 2020 |
| Hirsch Stanley | — | Award / Grant | 108,113 | — | — | 108,113 | Mar 9, 2020 |
| Harsch Mutya | Chief Legal Officer and GC | Award / Grant | 50,643 | — | — | 58,191 | Mar 9, 2020 |
| Hadar Ilan | CFO and Country Manager | Award / Grant | 69,012 | — | — | 77,351 | Mar 9, 2020 |
| Domzalski David | President and CEO | Award / Grant | 138,102 | — | — | 191,952 | Mar 9, 2020 |
| Bruno Anthony D | — | Award / Grant | 7,321 | — | — | 44,433 | Mar 9, 2020 |
| Basta Steven L | — | Award / Grant | 7,108 | — | — | 522,038 | Mar 9, 2020 |
| Basta Steven L | Chief Executive Officer | Option Exercise | 14,000 | $1.83 | $25,620 | 509,764 | Dec 11, 2019 |
| BALL KRISTINE M | See Remarks | Option Exercise | 80,300 | — | — | 80,300 | Dec 11, 2019 |
| Krasnow Ronald A. | See Remarks | Tax Withholding | 8,271 | $4.52 | $37,385 | 15,819 | Dec 11, 2019 |
| Kwon Paul | Chief Scientific Officer | Tax Withholding | 27,766 | $4.52 | $125,502 | 52,534 | Dec 11, 2019 |
| Basta Steven L | Chief Executive Officer | Tax Withholding | 85,210 | $4.52 | $385,149 | 495,764 | Dec 11, 2019 |
| Kwon Paul | Chief Scientific Officer | Option Exercise | 80,300 | — | — | 80,300 | Dec 11, 2019 |
| BALL KRISTINE M | See Remarks | Tax Withholding | 27,766 | $4.52 | $125,502 | 52,534 | Dec 11, 2019 |
| Watson James F | — | Sale | 487,500 | $7.65 | $3,729,375 | 1,907,568 | Jul 24, 2018 |
| Presidio Partners 2007 (Parallel), L.P. | — | Other | 152,062 | — | — | 152,062 | Mar 2, 2018 |
| Collier David J | — | C | 3,263 | — | — | 61,410 | Jan 29, 2018 |
| FMR LLC | — | C | 813,478 | — | — | 813,478 | Jan 29, 2018 |
| Cha Albert | — | C | 324,306 | — | — | 359,992 | Jan 25, 2018 |
| Vivo Capital Fund VIII, L.P. | — | C | 126,703 | — | — | 486,695 | Jan 25, 2018 |
| Remeditex Ventures LLC | — | C | 304,576 | — | — | 2,761,663 | Jan 25, 2018 |
| venBio Global Strategic Fund II L.P. | — | C | 1,196,552 | — | — | 1,461,552 | Jan 25, 2018 |